Reneuron Group PLC operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Reneuron Group PLC with three other
miscellaneous service companies in Europe:
E-Therapeutics Plc
(2019
sales of £44,000.00 [US$57,818.64 ]
of which 100%
was Drug Discovery & Development),
Biovica International AB
of Sweden
(3.01 million Swedish Kronor [US$315,194.45 ]
), and
Diamyd Medical Ab
which is
also
based in Sweden
(1.57 million Swedish Kronor [US$164,467.52 ]
).
Sales Analysis.
Reneuron Group PLC reported sales of £49,000.00 (US$64.39 thousand)
for the
fiscal
year ending
March of 2019.
This
represents
an
increase of 14.0%
versus 2018, when the company's sales were £43,000.00 .